ZONGERTINIB

167 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ZONGERTINIB:

# Side effect Count
0 DIARRHOEA 45
1 DISEASE PROGRESSION 25
2 MALIGNANT NEOPLASM PROGRESSION 21
3 METASTASES TO CENTRAL NERVOUS SYSTEM 13
4 RASH 11
5 NAUSEA 10
6 HEPATIC FUNCTION ABNORMAL 9
7 DEATH 8
8 DECREASED APPETITE 8
9 DYSPNOEA 5
See all common reactions for ZONGERTINIB

ZONGERTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 MUTANT NON-SMALL CELL LUNG CANCER 2 0.1818
1 OBTURATOR HERNIA 1 0.1250
2 LI-FRAUMENI SYNDROME 1 0.0625
3 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
4 IMMUNE-MEDIATED ARTHRITIS 1 0.0026
5 TUMOUR ASSOCIATED FEVER 1 0.0024
6 SCROTAL OEDEMA 1 0.0014
7 GENITAL INFECTION FUNGAL 1 0.0012
8 INTUSSUSCEPTION 1 0.0010
9 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
See all enriched reactions for ZONGERTINIB